BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18638294)

  • 1. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
    Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
    J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
    Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
    Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats.
    Wegner K; Robertson SA; Kollias-Baker C; Sams RA; Muir WW
    J Vet Pharmacol Ther; 2004 Oct; 27(5):329-36. PubMed ID: 15500571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels.
    Bhargava HN; Villar VM; Gulati A; Chari G
    J Pharmacol Exp Ther; 1991 Aug; 258(2):511-6. PubMed ID: 1865354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and hydromorphone for postoperative analgesia: focus on safety.
    Golembiewski JA
    J Perianesth Nurs; 2003 Apr; 18(2):120-2. PubMed ID: 12710006
    [No Abstract]   [Full Text] [Related]  

  • 12. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy Greyhounds.
    Kukanich B; Borum SL
    Am J Vet Res; 2008 May; 69(5):664-9. PubMed ID: 18447799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
    Krotscheck U; Boothe DM; Little AA
    Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs.
    Hofmeister EH; Chandler MJ; Read MR
    J Am Vet Med Assoc; 2010 Nov; 237(10):1155-9. PubMed ID: 21073386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of butorphanol in broiler chickens.
    Singh PM; Johnson C; Gartrell B; Mitchinson S; Chambers P
    Vet Rec; 2011 Jun; 168(22):588. PubMed ID: 21628341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy.
    Jeleazcov C; Saari TI; Ihmsen H; Mell J; Fröhlich K; Krajinovic L; Fechner J; Schüttler J
    Anesthesiology; 2014 Feb; 120(2):378-91. PubMed ID: 23958818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules.
    Vashi V; Harris S; El-Tahtawy A; Wu D; Cipriano A
    J Clin Pharmacol; 2005 May; 45(5):547-54. PubMed ID: 15831778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.